contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment CompanyTagList on Company {
  pageUrl
  name
  viewerIsFollowing
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    ...CompanyTagList
    id
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
      id
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    id
    name
    pageUrl
    viewerIsFollowing
    defaultInstrument {
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


axichem-ab-axichem-signs-agreement-with-actives-and-co-for-sales-and-distribution-of-axiviter-in-france

__typename

title

isPremium

lang

htmlBody

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

aXichem is active in industrial biotechnology. The company develops, patents and markets industrial chemicals. The company mainly works with Phenylcapsaicin, a natural analog synthetic capsaicin with applications in a variety of areas, such as in the marine sector, among pest control in forestry and agriculture, as well as among individual pharmaceutical work areas. Operations are run on a global level, with the head office in Malmö.

aXichem

aXichem AB (publ), that develops and markets natural analogue industrial compounds, has signed a marketing, sales and distribution agreement with the French company Actives & Co, a provider ...

aXichem AB (publ), that develops and markets natural analogue industrial compounds, has signed a marketing, sales and distribution agreement with the French company Actives &amp; Co, a provider of raw materials for food supplements, cosmetics and animal health, regarding aXichem's capsaicin analogue product, aXivite for dietary supplement.- We are looking forward to launching aXichem's unique ingredient in the French market. Weight management and intestinal health are ones of the major concerns in Europe. Most of our customers are looking for new raw materials that may allow them to bring efficient solutions to their own clients. Therefore, we see a great potential in aXivite® as the next generation substance in weight management, with a huge potential market, says Jean-Yves Moyroud, President of Actives &amp; Co- I am very happy to announce our distribution agreement with Actives &amp; Co, an innovative and professional supplier of ingredients. France is Europe's third largest market when it comes to food- and dietary supplements. aXivite® offers documented health benefits, making it an interesting and competitive ingredient for food supplement producers active in these market segments, says Lucas Altepost, Vice President of aXichem. The French market for food supplements is the third largest market in Europe, behind Italy and Germany, at 610 million Euro in 2013, (FederSalus, 2014). Some sources have estimated the market to be even bigger. The Syndicat National de Compléments Alimentaires (Synadiet) estimates the French market to be much larger at 1.48 billion Euro in 2014, having increased by 6.4 percent since 2013. According to Synadiet, the most popular categories in 2014 were tonics, stress and sedatives, digestion and weight control supplements.About Actives &amp; Co Actives &amp; Co is a young and dynamic French company, founded in 2015 in Lyon on the initiative and with the support of European raw material manufacturers respectively located in Germany and Spain. Actives &amp; Co's main clients are food supplement manufacturers, cosmetics companies and veterinary companies. The company promotes and markets innovative, efficient and well documented technical raw materials.This press release has been translated from Swedish. The Swedish text shall govern for all purposes and prevail in case of any discrepancy with the English version.

aXichem AB: aXichem signs agreement with Actives & Co for sales and distribution of aXivite® in France